Effect of Sustained Use of Aspirin until the Time of Surgery on Outcomes following Coronary Artery Bypass Grafting: A Randomized Clinical Trial
Conclusion Sustained ASA use until the day of surgery in patients planned for elective isolated CABG can result in excessive bleeding, increased rate of reexploration, and need for more PRBC transfusion without any proven beneficial effect on reducing unfavorable postoperative outcomes. Hence, we recommend discontinuing ASA between 3 and 5 days before non-urgent CABG while keeping it on in nonelective circumstances. [...] Georg Thieme Verlag KG Stuttgart · New YorkArticle in Thieme eJournals: Table of contents | Abstract | Full text
Source: The Thoracic and Cardiovascular Surgeon - Category: Cardiovascular & Thoracic Surgery Authors: Sharifi, Mehrzad Kamali, Alireza Ghandi, Yazdan Tags: Original Cardiovascular Source Type: research
More News: Aspirin | Bleeding | Cardiology | Cardiovascular | Cardiovascular & Thoracic Surgery | Clinical Trials | Coronary Artery Bypass Graft | Heart | Heart Attack | Renal Failure | Statistics | Stroke | Study